Millenium Healthcare Inc (MHCC) 0.5900 $MHCC
Millennium Healthcare Working to Help Prevent Oral Cancers With the OralCDx Brush Biopsy Test
PR Newswire - Wed Jun 25, 7:30AM CDT
Millennium HealthCare Inc. (MHCC) through its subsidiary, Millennium Medical Devices LLC, has an exclusive agreement with CDx Diagnostics to distribute its OralCDx brush biopsy test kit. OralCDx is a non-invasive test that is used to test dysplasia (the small white and red tissue spots commonly found in the mouth) to rule out precancerous change. The test has previously been available to dentists nationwide, and has already resulted in the prevention of thousands of oral cancers. Through this exclusive collaboration, Primary Care Physicians will be able to administer this test to their patients.
Millennium Healthcare Inc. Advances Patient Care With VasoScan Cardiovascular Assessment Test
PR Newswire - Mon Jun 23, 8:27AM CDT
Millennium HealthCare Inc. (OTCBB: MHCC) through its wholly owned subsidiary, Millennium Medical Devices, LLC is assisting primary care physicians to offer their patients breakthrough diagnostics that are reimbursable by Medicare and private insurance companies.
Millennium HealthCare Positioned To Become A Leader In Medical Device Distribution
PR Newswire - Wed May 21, 7:55AM CDT
Millennium HealthCare Inc. (OTCBB: MHCC) today announced the continued expansion of its distribution network, positioning the Company to become a leading distributor of medical devices for preventative care and early detection of serious medical issues. Millennium, through its wholly owned operating subsidiary Millennium Medical Devices, LLC, provides primary care physician practices, physician groups and healthcare facilities of all sizes with cutting edge medical devices such as the VasoScan Cardiovascular Assessment Test, the OralCDX Brush Biopsy Test and the DermCDx Biopsy test. There are over 400,000 primary care physicians in the United States who could utilize these tests in their practices.
Millennium HealthCare CEO Reports on Operational Developments and Progress
PR Newswire - Mon Mar 31, 10:00AM CDT
Millennium HealthCare Inc. (OTCBB: MHCC) today issued a statement from its Chief Executive Officer, Dominick Sartorio, providing an update on corporate developments over the past year. The statement is included in its entirety below:
Millennium HealthCare Inc. Continues Customer Growth; Revenues Could Exceed $150,000,000 With Addition of New Network Selling Agreement
PR Newswire - Mon Mar 10, 7:30AM CDT
Millennium HealthCare Inc. (OTCBB: MHCC) today announced that its subsidiary, Millennium Medical Devices LLC, has signed a network selling agreement with another US based healthcare organization for the use of its medical devices in 100 of the organization's locations. This agreement includes an average monthly minimum use of 350 units, per device, per location. This new agreement combined with the agreement as reported in the Company's February 27th press release will bring the total number of contracted locations to 300.
Millennium HealthCare Inc. Signs Network Selling Agreement with Large Physician Practice Network
PR Newswire - Thu Feb 27, 7:52AM CST
Millennium HealthCare Inc. (OTCBB: MHCC) today announced that its subsidiary, Millennium Medical Devices LLC, has signed a network selling agreement with a US based healthcare organization for the use of its medical devices in 200 of the organization's locations. This agreement includes an average monthly minimum use of 350 units per location.
Millennium Medical Devices Signs an Exclusive Distribution Agreement with CDx Diagnostics to Distribute the DermCDx(TM) Skin Cancer Test Kit
PR Newswire - Thu Feb 20, 7:00AM CST
Millennium HealthCare Inc. (OTCBB: MHCC) today announced that its subsidiary, Millennium Medical Devices LLC, has signed an exclusive agreement with CDx Diagnostics for distribution of DermCDx(TM) , a brush biopsy test kit that is used to confirm suspected basal cell carcinoma (BCC), the most common cancer in the US. DermCDx is a minimally invasive test that combines a patented brush biopsy sampling instrument with computer-assisted three dimensional laboratory analysis. It is designed to allow primary care physicians to easily confirm suspected BCC resulting in expedited referral to a dermatologist for treatment. According to the American Academy of Dermatology, basal cell carcinoma (BCC) is the most common form of skin cancer. With over 2 million new cases diagnosed each year it is also the most common cancer in the United States. While this type of skin cancer usually grows slowly, early diagnosis and treatment is important because it can grow both wide and deep, destroying much skin tissue and bone, resulting in both disfigurement and loss of function. "We developed DermCDx(TM) for use by the primary care physician to facilitate the earlier diagnosis of basal cell carcinomas, allowing for earlier referral and treatment by the dermatologist" said Dr. Drore Eisen, MD, DDS, Medical Director of CDx Diagnostics.
Millennium Medical Devices Begins Rollout of CDx Diagnostics' OralCDx Brush Biopsy Test
PR Newswire - Wed Feb 12, 7:31AM CST
Millennium HealthCare Inc. (OTCBB: MHCC) today announced that its subsidiary, Millennium Medical Devices LLC, through a signed exclusive agreement with CDx Diagnostics, will begin its rollout and distribution of the OralCDx brush biopsy test kit. OralCDx is a non-invasive test that is used to test the small white and red tissue spots commonly found in the mouth to rule out precancerous change. The test has previously been available to dentists nationwide, and has already resulted in the prevention of thousands of oral cancers. Through this exclusive collaboration, Primary Care Physicians will be able to administer this test to their patients.
CodeSmart(TM) Partners With Millennium HealthCare, Inc. to Market Its ICD-10 Educational and Consulting Services for Medical Practices and Hospitals
GlobeNewswire - Thu Aug 22, 7:40AM CDT
CodeSmart Holdings, Inc. (OTCQB:ITEN), with its subsidiary, The CODESMART Group, Inc. (collectively, "CODESMART"
, a premier ICD-10 education and solutions group that offers CODESMART UNIVERSITY, its on-line education solution and customizable training solutions, announces today that it has licensed Millennium HealthCare, Inc. (OTCPINK:MHCC) to serve as a marketing partner of its ICD-10 consulting and education programs, including CODESMART UNIVERSITY, to physicians, physician practices and hospitals.
Millennium HealthCare Inc. Featured in Forbes
PR Newswire - Wed Aug 14, 8:00AM CDT
Millennium HealthCare Inc. (OTC Pink: MHCC) announced today that it was featured in an article by Gene Marcial in Forbes, titled "Obamacare Focuses On Prevention And Wellness By Spending More On Medical Tests". The full article can be accessed on Forbes' website at: http://www.forbes.com/sites/genemarcial/2013/...r=yahootix
Millennium HealthCare Signs Exclusive Distribution Agreement with eWellness Corporation for Northeast and Mid-Atlantic Regions
PR Newswire - Tue Jun 18, 8:06AM CDT
Millennium HealthCare Inc. (OTC Pink: MHCC) today announced that it has entered into an exclusive 25-year Supply and Distribution agreement for the Northeast and Mid-Atlantic regions with eWellness Corporation ("EWC" for its Distance Monitored Physical Therapy Program ("DMpt" .
Atossa Genetics Reports First Quarter 2013 Results and Operating Highlights
Marketwire - Wed May 15, 7:30AM CDT
Atossa Genetics, Inc. (NASDAQ: ATOS), the Breast Health Company(TM), today announced its first quarter 2013 financial results and corporate developments.
Millennium HealthCare Signs Exclusive Distribution Agreement with Heart Smart Inc.
PR Newswire - Wed May 08, 8:00AM CDT
Millennium HealthCare Inc. (OTC Pink: MHCC) today announced that its Medical Device subsidiary signed an exclusive distribution agreement with Heart Smart Inc. for the VasoScan assessment device. VasoScan is an FDA cleared, simple, non-invasive device which provides an accurate, reproducible assessment of the Autonomic Nervous System, vascular elasticity and stiffness, as well as the coronary health of "at-risk" patients in less than 5 minutes. The non-invasive test uses an LED/Photodiode finger probe sensor to observe changes in pressure, blood flow and velocity throughout the pulse wave.
Millennium HealthCare Inc enters into distribution agreement with Atossa Genetics for breast cancer kits
M2 - Fri May 03, 9:22AM CDT
Breast health company Millennium HealthCare Inc (OTC Pink:MHCC) revealed on Thursday the launch of an agreement to market Atossa Genetics Inc's (ATOS) ForeCYTE Breast Health devices.
Atossa Genetics Signs Distribution Agreement With Millennium HealthCare
Marketwire - Thu May 02, 8:00AM CDT
Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company(TM), has signed an agreement with Millennium HealthCare Inc. (PINKSHEETS: MHCC) for the distribution by Millennium Medical Devices of Atossa's ForeCYTE Breast Health devices, which consist of the patented MASCT pump and ForeCYTE patient collection kits. Millennium has submitted an initial order for 10,000 ForeCYTE collection kits, which it intends to market to managed-care networks, healthcare clinics and physician practices in the New York Metro Area and Northern New Jersey.
Millennium HealthCare Signs Distribution Agreement with Atossa Genetics
PR Newswire - Thu May 02, 8:00AM CDT
Millennium HealthCare Inc. (OTC Pink: MHCC) today announced that its Medical Device subsidiary signed an agreement with Atossa Genetics Inc. (NASDAQ: ATOS) for the distribution of Atossa's ForeCYTE Breast Health devices, which consist of the patented MASCT pump and ForeCYTE patient collection kits. Millennium has submitted an initial order for 10,000 ForeCYTE collection kits, which it intends to market to managed-care networks, healthcare clinics and physician practices in the New York Metro Area and Northern New Jersey.
Millennium HealthCare signs exclusive nationwide distribution agreement for an Oral Cancer Biopsy Test
PR Newswire - Tue Mar 05, 8:27AM CST
Millennium HealthCare Inc. (OTC Pink: MHCC) signed an exclusive nationwide distribution agreement for an Oral Diagnostics Biopsy test. This non-invasive full thickness biopsy can be used to rule out oral dysplasia or cancer.
Millennium Administrators, Inc. Has Been Selected by Abington Heights School District, Clarks Summit, Pennsylvania to provide Benefit Administration.
PRWeb - Mon Mar 04, 3:31PM CST
Millennium Administrators, Inc., a healthcare benefits administrator, has signed a contract with the Abington Heights School District to provide benefit administration services for over 1300 district employees. Millennium is providing administrative oversight for the district's medical benefit program, including cost containment initiatives, pharmacy management and administrative services to enhance healthcare cost saving initiatives.
Millennium Healthcare Working to Help Prevent Oral Cancers With the OralCDx Brush Biopsy Test
PR Newswire - Wed Jun 25, 7:30AM CDT
Millennium HealthCare Inc. (MHCC) through its subsidiary, Millennium Medical Devices LLC, has an exclusive agreement with CDx Diagnostics to distribute its OralCDx brush biopsy test kit. OralCDx is a non-invasive test that is used to test dysplasia (the small white and red tissue spots commonly found in the mouth) to rule out precancerous change. The test has previously been available to dentists nationwide, and has already resulted in the prevention of thousands of oral cancers. Through this exclusive collaboration, Primary Care Physicians will be able to administer this test to their patients.
Millennium Healthcare Inc. Advances Patient Care With VasoScan Cardiovascular Assessment Test
PR Newswire - Mon Jun 23, 8:27AM CDT
Millennium HealthCare Inc. (OTCBB: MHCC) through its wholly owned subsidiary, Millennium Medical Devices, LLC is assisting primary care physicians to offer their patients breakthrough diagnostics that are reimbursable by Medicare and private insurance companies.
Millennium HealthCare Positioned To Become A Leader In Medical Device Distribution
PR Newswire - Wed May 21, 7:55AM CDT
Millennium HealthCare Inc. (OTCBB: MHCC) today announced the continued expansion of its distribution network, positioning the Company to become a leading distributor of medical devices for preventative care and early detection of serious medical issues. Millennium, through its wholly owned operating subsidiary Millennium Medical Devices, LLC, provides primary care physician practices, physician groups and healthcare facilities of all sizes with cutting edge medical devices such as the VasoScan Cardiovascular Assessment Test, the OralCDX Brush Biopsy Test and the DermCDx Biopsy test. There are over 400,000 primary care physicians in the United States who could utilize these tests in their practices.
Millennium HealthCare CEO Reports on Operational Developments and Progress
PR Newswire - Mon Mar 31, 10:00AM CDT
Millennium HealthCare Inc. (OTCBB: MHCC) today issued a statement from its Chief Executive Officer, Dominick Sartorio, providing an update on corporate developments over the past year. The statement is included in its entirety below:
Millennium HealthCare Inc. Continues Customer Growth; Revenues Could Exceed $150,000,000 With Addition of New Network Selling Agreement
PR Newswire - Mon Mar 10, 7:30AM CDT
Millennium HealthCare Inc. (OTCBB: MHCC) today announced that its subsidiary, Millennium Medical Devices LLC, has signed a network selling agreement with another US based healthcare organization for the use of its medical devices in 100 of the organization's locations. This agreement includes an average monthly minimum use of 350 units, per device, per location. This new agreement combined with the agreement as reported in the Company's February 27th press release will bring the total number of contracted locations to 300.
Millennium HealthCare Inc. Signs Network Selling Agreement with Large Physician Practice Network
PR Newswire - Thu Feb 27, 7:52AM CST
Millennium HealthCare Inc. (OTCBB: MHCC) today announced that its subsidiary, Millennium Medical Devices LLC, has signed a network selling agreement with a US based healthcare organization for the use of its medical devices in 200 of the organization's locations. This agreement includes an average monthly minimum use of 350 units per location.
Millennium Medical Devices Signs an Exclusive Distribution Agreement with CDx Diagnostics to Distribute the DermCDx(TM) Skin Cancer Test Kit
PR Newswire - Thu Feb 20, 7:00AM CST
Millennium HealthCare Inc. (OTCBB: MHCC) today announced that its subsidiary, Millennium Medical Devices LLC, has signed an exclusive agreement with CDx Diagnostics for distribution of DermCDx(TM) , a brush biopsy test kit that is used to confirm suspected basal cell carcinoma (BCC), the most common cancer in the US. DermCDx is a minimally invasive test that combines a patented brush biopsy sampling instrument with computer-assisted three dimensional laboratory analysis. It is designed to allow primary care physicians to easily confirm suspected BCC resulting in expedited referral to a dermatologist for treatment. According to the American Academy of Dermatology, basal cell carcinoma (BCC) is the most common form of skin cancer. With over 2 million new cases diagnosed each year it is also the most common cancer in the United States. While this type of skin cancer usually grows slowly, early diagnosis and treatment is important because it can grow both wide and deep, destroying much skin tissue and bone, resulting in both disfigurement and loss of function. "We developed DermCDx(TM) for use by the primary care physician to facilitate the earlier diagnosis of basal cell carcinomas, allowing for earlier referral and treatment by the dermatologist" said Dr. Drore Eisen, MD, DDS, Medical Director of CDx Diagnostics.
Millennium Medical Devices Begins Rollout of CDx Diagnostics' OralCDx Brush Biopsy Test
PR Newswire - Wed Feb 12, 7:31AM CST
Millennium HealthCare Inc. (OTCBB: MHCC) today announced that its subsidiary, Millennium Medical Devices LLC, through a signed exclusive agreement with CDx Diagnostics, will begin its rollout and distribution of the OralCDx brush biopsy test kit. OralCDx is a non-invasive test that is used to test the small white and red tissue spots commonly found in the mouth to rule out precancerous change. The test has previously been available to dentists nationwide, and has already resulted in the prevention of thousands of oral cancers. Through this exclusive collaboration, Primary Care Physicians will be able to administer this test to their patients.
CodeSmart(TM) Partners With Millennium HealthCare, Inc. to Market Its ICD-10 Educational and Consulting Services for Medical Practices and Hospitals
GlobeNewswire - Thu Aug 22, 7:40AM CDT
CodeSmart Holdings, Inc. (OTCQB:ITEN), with its subsidiary, The CODESMART Group, Inc. (collectively, "CODESMART"
, a premier ICD-10 education and solutions group that offers CODESMART UNIVERSITY, its on-line education solution and customizable training solutions, announces today that it has licensed Millennium HealthCare, Inc. (OTCPINK:MHCC) to serve as a marketing partner of its ICD-10 consulting and education programs, including CODESMART UNIVERSITY, to physicians, physician practices and hospitals. Millennium HealthCare Inc. Featured in Forbes
PR Newswire - Wed Aug 14, 8:00AM CDT
Millennium HealthCare Inc. (OTC Pink: MHCC) announced today that it was featured in an article by Gene Marcial in Forbes, titled "Obamacare Focuses On Prevention And Wellness By Spending More On Medical Tests". The full article can be accessed on Forbes' website at: http://www.forbes.com/sites/genemarcial/2013/...r=yahootix
Millennium HealthCare Signs Exclusive Distribution Agreement with eWellness Corporation for Northeast and Mid-Atlantic Regions
PR Newswire - Tue Jun 18, 8:06AM CDT
Millennium HealthCare Inc. (OTC Pink: MHCC) today announced that it has entered into an exclusive 25-year Supply and Distribution agreement for the Northeast and Mid-Atlantic regions with eWellness Corporation ("EWC"
for its Distance Monitored Physical Therapy Program ("DMpt" . Atossa Genetics Reports First Quarter 2013 Results and Operating Highlights
Marketwire - Wed May 15, 7:30AM CDT
Atossa Genetics, Inc. (NASDAQ: ATOS), the Breast Health Company(TM), today announced its first quarter 2013 financial results and corporate developments.
Millennium HealthCare Signs Exclusive Distribution Agreement with Heart Smart Inc.
PR Newswire - Wed May 08, 8:00AM CDT
Millennium HealthCare Inc. (OTC Pink: MHCC) today announced that its Medical Device subsidiary signed an exclusive distribution agreement with Heart Smart Inc. for the VasoScan assessment device. VasoScan is an FDA cleared, simple, non-invasive device which provides an accurate, reproducible assessment of the Autonomic Nervous System, vascular elasticity and stiffness, as well as the coronary health of "at-risk" patients in less than 5 minutes. The non-invasive test uses an LED/Photodiode finger probe sensor to observe changes in pressure, blood flow and velocity throughout the pulse wave.
Millennium HealthCare Inc enters into distribution agreement with Atossa Genetics for breast cancer kits
M2 - Fri May 03, 9:22AM CDT
Breast health company Millennium HealthCare Inc (OTC Pink:MHCC) revealed on Thursday the launch of an agreement to market Atossa Genetics Inc's (ATOS) ForeCYTE Breast Health devices.
Atossa Genetics Signs Distribution Agreement With Millennium HealthCare
Marketwire - Thu May 02, 8:00AM CDT
Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company(TM), has signed an agreement with Millennium HealthCare Inc. (PINKSHEETS: MHCC) for the distribution by Millennium Medical Devices of Atossa's ForeCYTE Breast Health devices, which consist of the patented MASCT pump and ForeCYTE patient collection kits. Millennium has submitted an initial order for 10,000 ForeCYTE collection kits, which it intends to market to managed-care networks, healthcare clinics and physician practices in the New York Metro Area and Northern New Jersey.
Millennium HealthCare Signs Distribution Agreement with Atossa Genetics
PR Newswire - Thu May 02, 8:00AM CDT
Millennium HealthCare Inc. (OTC Pink: MHCC) today announced that its Medical Device subsidiary signed an agreement with Atossa Genetics Inc. (NASDAQ: ATOS) for the distribution of Atossa's ForeCYTE Breast Health devices, which consist of the patented MASCT pump and ForeCYTE patient collection kits. Millennium has submitted an initial order for 10,000 ForeCYTE collection kits, which it intends to market to managed-care networks, healthcare clinics and physician practices in the New York Metro Area and Northern New Jersey.
Millennium HealthCare signs exclusive nationwide distribution agreement for an Oral Cancer Biopsy Test
PR Newswire - Tue Mar 05, 8:27AM CST
Millennium HealthCare Inc. (OTC Pink: MHCC) signed an exclusive nationwide distribution agreement for an Oral Diagnostics Biopsy test. This non-invasive full thickness biopsy can be used to rule out oral dysplasia or cancer.
Millennium Administrators, Inc. Has Been Selected by Abington Heights School District, Clarks Summit, Pennsylvania to provide Benefit Administration.
PRWeb - Mon Mar 04, 3:31PM CST
Millennium Administrators, Inc., a healthcare benefits administrator, has signed a contract with the Abington Heights School District to provide benefit administration services for over 1300 district employees. Millennium is providing administrative oversight for the district's medical benefit program, including cost containment initiatives, pharmacy management and administrative services to enhance healthcare cost saving initiatives.
